Alberto Garaventa

7PUBLICATIONS
70CO-AUTHORS
Haematological tumoursPredictive and prognostic markersObstetrics and gynaecologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 12, 2026
Immunoprofiling, sex- and age-related determinants of treatment response in paediatric, adolescent and young adult Hodgkin lymphoma.

Valli De Re, Egesta Lopci, Giulia Brisotto

|Aug 19, 2025
Neuroblastoma in Infants: Long-Term Survival From INES Protocols A SIOPEN Study.

Julie Savagner, Caroline Munzer, Gudrun Schleiermacher

|Jul 08, 2025
Fcγ Receptor Polymorphism in Patients with Relapsed/Refractory High-Risk Neuroblastoma Correlates with Outcomes in the SIOPEN Dinutuximab Beta Long-Term Infusion Trial.

Holger N Lode, Nikolai Siebert, Dominique Valteau-Couanet

|Feb 21, 2025
Spontaneous conception and pregnancy outcomes after multi-agent chemotherapy and high-dose radiotherapy for pelvic Ewing sarcoma: Case report and literature review.

Valentina Tosto, Federico Prefumo, Carolina Scala

|Jun 03, 2022
Brentuximab vedotin in the treatment of paediatric patients with relapsed or refractory Hodgkin's lymphoma: Results of a real-life study.

Davide Massano, Elisa Carraro, Lara Mussolin

|Jan 22, 2020
Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients.

Marzia Ognibene, Martina Morini, Alberto Garaventa

Pageof 2

Frequent Collaborators

2 joint publications

Marta Pillon

2 joint publications

Ruth Ladenstein

2 joint publications

Dominique Valteau-Couanet

2 joint publications

Roberto Luksch